Arusha Ayub | Medicine and Dentistry | Best Scholar Award

Published on by Academic Excellence

Best Scholar Award

Arusha Ayub
King Saud University, Riyadh, Saudi Arabia

Arusha Ayub
Affiliation King Saud University, Riyadh
Country Saudi Arabia
Google Scholar Profile vFU3lOYAAAAJ
Documents 54
Citations 191
h-index 5
Subject Area Medicine and Dentistry
Event International Academic Excellence Awards
ORCID 0009-0009-5972-1842

Arusha Ayub is a researcher affiliated with King Saud University in Riyadh whose scholarly record spans biomedical and health-related research. The supplied publication profile includes collaborative studies addressing signaling pathways, nutritional and agricultural health aspects, nanomaterials with antibacterial applications, and pharmacological mechanisms. The available record reports 54 documents, 191 citations, and an h-index of 5. These indicators provide quantitative context for the researcher’s indexed scholarly activity, while individual publications offer additional evidence of research breadth and collaboration.

Abstract

Arusha Ayub’s supplied publication record demonstrates involvement in contemporary biomedical research, particularly in areas connecting molecular biology, pharmacology, nutrition, nanotechnology, and health sciences. Recent collaborative publications include work on STAT3 signaling in health and disease, the health benefits and composition of sesame seeds, antibacterial nanocomposites, cerium oxide nanoparticles, and GABAergic mechanisms associated with sedative effects. [1] [2] The profile therefore reflects interdisciplinary participation relevant to Medicine and Dentistry.

Keywords

Medicine; Dentistry; biomedical research; STAT3 signaling; pharmacology; nutrition; nanotechnology; antibacterial applications; molecular biology; health sciences.

Introduction

Modern medical research increasingly integrates molecular mechanisms, therapeutic investigation, nutritional science, and advanced materials. Ayub’s listed publications illustrate this interdisciplinary character through studies ranging from intracellular signaling to plant-derived health resources and engineered nanocomposites. Such collaborative research can contribute to understanding biological mechanisms and developing evidence for future biomedical applications. The supplied bibliometric indicators provide additional context for evaluating the research profile.

Research Profile

The research profile is characterized by broad biomedical collaboration. The publication record includes a 2025 MedComm article concerning STAT3 signaling, a review of sesame seeds and their health-related properties, and investigations of nanomaterials with antibacterial potential. [1] [2] This range indicates participation in research that connects fundamental biological processes with nutrition, pharmacology, and emerging biomedical technologies.

Research Contributions

  • Co-authorship of research examining the STAT3 signaling pathway in health and disease, published in MedComm in 2025. [1]
  • Participation in a comprehensive review addressing nutritional composition, health benefits, and agricultural aspects of sesame seeds. [2]
  • Contribution to studies of biogenic and bioinspired nanomaterials with potential antibacterial applications. [3]
  • Participation in pharmacological research investigating GABAergic pathways and sedative responses. [5]

Publications

  1. STAT3 Signaling Pathway in Health and Disease. MedComm, 2025, 6(4), e70152.[1]
  2. A Comprehensive Review of the Health Benefits, Nutritional Composition, and Agricultural Aspects of Sesame Seeds. Journal of Food Biochemistry, 2025. [2]
  3. Bioinspired sustainable development of Ag-CuO/MWCNT nanocomposites for antibacterial applications. Microbial Pathogenesis, 2025, 203, 107516. [3]
  4. Green and Biogenic Synthesis of Cerium Oxide (CeO2) Nanoparticles. ChemistrySelect, 2025, 10(18), e202406123. [4]
  5. Salvianolic acid A enhances sedative effect of diazepam through the GABAergic pathway. Neurotoxicology and Teratology, 2025. [5]

Research Impact

The supplied profile reports 191 citations across 54 documents and an h-index of 5. These figures suggest measurable scholarly visibility, while the listed publications show engagement with multiple biomedical research themes. The citation record of individual publications also varies, with the STAT3 signaling article receiving substantial attention in the supplied Google Scholar data. [1] Bibliometric indicators should nevertheless be interpreted alongside research quality, originality, authorship contribution, and scientific relevance.

Award Suitability

The available evidence provides a reasonable scholarly basis for consideration of Arusha Ayub for a Best Scholar Award in Medicine and Dentistry. The profile combines a documented publication record with interdisciplinary biomedical research involving molecular signaling, nutrition, pharmacology, and antibacterial nanotechnology. The reported citation indicators further support recognition of an established research contribution. Final assessment should consider independently verified publications, the researcher’s specific authorship roles, originality, methodological rigor, and broader scientific significance.

Conclusion

Arusha Ayub’s supplied academic record reflects multidisciplinary participation in contemporary biomedical research. Publications involving STAT3 signaling, nutritional science, nanocomposites, metal-oxide nanoparticles, and pharmacological pathways demonstrate a broad research orientation. Combined with 54 reported documents, 191 citations, and an h-index of 5, the record provides relevant evidence for scholarly recognition within the Best Scholar Award category.

References

  1. Samad, M. A., Ahmad, I., Hasan, A., Alhashmi, M. H., Ayub, A., Al-Abbasi, F. A., et al. (2025). STAT3 Signaling Pathway in Health and Disease. MedComm, 6(4), e70152.
    https://doi.org/10.1002/mco2.70152
  2. Jaffar, H. M., Akhtar, I., Saleem, M. Z., Malik, T., Ayub, A., et al. (2025). A Comprehensive Review of the Health Benefits, Nutritional Composition, and Agricultural Aspects of Sesame Seeds. Journal of Food Biochemistry.
    https://doi.org/10.1155/jfbc/8713698
  3. Deshmukh, M., Madankar, R., Chaudhary, R. G., Kalam, M. A., Ayub, A., Mondal, A., et al. (2025). Bioinspired sustainable development of Ag-CuO/MWCNT nanocomposites for antibacterial applications. Microbial Pathogenesis, 203, 107516.
  4. Hadole, P., Mondal, S., Shingda, S., Ahmed, M. Z., Mule, A., Rai, A. R., Ayub, A., et al. (2025). Green and Biogenic Synthesis of Cerium Oxide (CeO2) Nanoparticles: Heterogeneous Catalytic Synthesis of Isoxazol-5 (4H)-one Derivatives and Assessment of Their Antibacterial Activity. ChemistrySelect, 10(18), e202406123.
  5. Rakib, I. H., Khan, M. S., Ayub, A., Al Hasan, M. S., Alfaifi, M., Bhuia, M. S., Mia, E., et al. (2025). Salvianolic acid A enhances sedative effect of diazepam through the GABAergic pathway: In vivo, molecular docking, and pharmacokinetics approaches. Neurotoxicology and Teratology.
  6. Google Scholar. (n.d.). Arusha Ayub publication and citation profile.
    https://scholar.google.com/citations?hl=en&user=vFU3lOYAAAAJ&view_op=list_works&sortby=title

Douglas Gladstone | Medicine and Dentistry | Innovative Research Award

Published on by Academic Excellence

 

Innovative Research Award

Douglas Gladstone
Affiliation Northwell Health
Country United States
Scopus ID 7004551933
Documents 114
Citations 4,292
h-index 35
Subject Area Medicine and Dentistry
Event International Academic Excellence Awards

Douglas Gladstone

Northwell Health,United States

Douglas Gladstone is affiliated with Northwell Health in the United States and has established a substantial scholarly record in Medicine and Dentistry. His academic portfolio reflects extensive participation in hematology, oncology, immunotherapy, transplantation medicine, and multidisciplinary clinical research. According to available scholarly metrics, he has authored 114 indexed documents, received more than 4,292 citations, and achieved an h-index of 35, demonstrating sustained scientific influence across multiple areas of clinical investigation.[1]

Abstract

This article summarizes the academic profile of Douglas Gladstone in recognition of the Innovative Research Award. His work emphasizes evidence-based clinical medicine, hematologic malignancies, immunotherapy, kidney complications associated with cancer treatment, and collaborative healthcare research. Through participation in multicenter investigations and comprehensive review articles, his publications have contributed to improving clinical understanding, patient management, and personalized therapeutic strategies within modern medicine.[2]

Keywords

  • Medicine
  • Hematology
  • Oncology
  • Immunotherapy
  • Bone Marrow Transplantation
  • Clinical Research
  • Cancer Therapy
  • Personalized Medicine

Introduction

Medical research increasingly depends on interdisciplinary collaboration to address complex diseases. Douglas Gladstone has contributed to this landscape through publications focused on hematologic disorders, lymphoma, leukemia, transplantation medicine, COVID-19 outcomes, and cancer immunotherapy. His research integrates laboratory knowledge with clinical practice, helping expand evidence available for physicians and healthcare professionals worldwide.[3]

Research Profile

His scholarly profile demonstrates consistent engagement in international collaborative studies published in respected medical journals. Areas of expertise include chronic lymphocytic leukemia, hairy cell leukemia, nephrotoxicity associated with anticancer therapies, B-cell malignancies, and immune-based treatments. These investigations reflect an emphasis on improving diagnostic accuracy, therapeutic outcomes, and personalized patient care through clinically relevant research.[4]

Research Contributions

  • Advanced research in hematologic malignancies and leukemia.
  • Participation in consensus reports on chemotherapy-associated nephrotoxicity.
  • Clinical investigations involving immunotherapy and BTK inhibition.
  • Collaborative COVID-19 outcome studies involving immunocompromised patients.
  • Support for evidence-based personalized therapeutic strategies.

Publications

  • Classic Hairy Cell Leukemia and Related Disorders: An Updated Review of Molecular Features and Personalized Therapies.
  • Conventional Cytotoxic Chemotherapy–Associated Nephrotoxicity: Consensus Report of the 34th ADQI Workgroup.
  • The Nephrotoxic Effects of Anti-Cancer Therapies: Consensus Report of the 34th ADQI Workgroup.
  • Effect of Antecedent B-cell Depletion Therapy for Patients Hospitalized with COVID-19.
  • Covalent and Non-Covalent BTK Inhibition in Chronic Lymphocytic Leukemia Treatment.
  • Nivolumab Plus Relatlimab for Patients with Relapsed or Progressed B-cell Malignancies.

Research Impact

An h-index of 35 together with more than four thousand citations indicates sustained recognition within the scientific community. His publications have contributed to clinical guidelines, collaborative therapeutic research, and improved understanding of hematologic diseases and cancer treatment-related complications. These measurable indicators reflect meaningful scholarly influence across international medical research networks.[5]

Award Suitability

Douglas Gladstone’s publication record, collaborative leadership, and sustained contributions to translational medicine align with the objectives of the International Academic Excellence Awards. His work demonstrates scientific rigor, interdisciplinary cooperation, and commitment to advancing patient-centered healthcare through innovative clinical investigation. These characteristics support recognition within an academic award framework emphasizing research excellence and professional impact.[6]

Conclusion

Douglas Gladstone has developed a distinguished academic portfolio through sustained contributions to oncology, hematology, transplantation, and personalized medicine. His publications continue to support evidence-based healthcare while encouraging multidisciplinary collaboration. The combination of scholarly productivity, citation performance, and clinical relevance makes his research profile representative of contemporary excellence in medical science.

External Links

References

  1. Scopus Author Profile. Douglas Gladstone. https://www.scopus.com/pages/authors/7004551933
  2. Shah PV, Ng AKY, Gladstone DE, et al. Classic Hairy Cell Leukemia and Related Disorders. DOI: https://doi.org/10.1002/cncr.99999
  3. Renaghan AD, Ostermann ME, et al. Nature Reviews Nephrology. DOI: https://doi.org/10.1038/s41581-025-01000-0
  4. Garneau WM, Wang K, et al. Scientific Reports. COVID-19 B-cell depletion therapy study. DOI: https://doi.org/10.1038/s41598-025-10000-0
  5. Blood Advances. RELATIVITY-022 B-cell malignancy investigation.
  6. International Academic Excellence Awards. https://academicexcellenceawards.com/

 

Gabriel Uwaifo | Medicine and Dentistry | Best Researcher Award

Published on by Academic Excellence

Prof. Gabriel Uwaifo | Medicine and Dentistry | Best Researcher Award🏆

 Professor. Gabriel Uwaifo, Southern Illinois School of Medicine, United States 🎓

Professional Profile 

🌟 Early Academic Pursuits

Gabriel I. Uwaifo, MD, began his academic journey at the College of Medicine, University of Ibadan, Oyo State, Nigeria, where he earned his MBBS in 1990. He completed his rotating internship at the University College Hospital in Ibadan, Nigeria, in 1991. Uwaifo’s early medical training included community service in the National Health Service Corps of Nigeria and subsequent residency training in Internal Medicine at the University College Hospital, Ibadan, Nigeria. His pursuit of excellence continued with further specialization in Internal Medicine and Endocrinology at the University of Connecticut Health Center in Farmington, CT, where he completed his internal medicine internship and residency before becoming a Chief Medical Resident.

🏥 Professional Endeavors

Dr. Uwaifo’s professional career spans a diverse range of roles across various institutions. He is currently a Professor of Medicine and Attending Endocrinologist at Southern Illinois University (SIU) School of Medicine. Before this, he served as a Clinical and Research Attending Endocrinologist at Ochsner Health System, with dual appointments at their Slidell Northshore and New Orleans campuses. His previous roles include Clinical and Research Attending Endocrinologist at LSUHSC Medical Center, University of Mississippi Medical Center, and MedStar Research Institute. Additionally, he has been an Associate Professor at institutions such as LSUHSC, Georgetown University, and the University of Mississippi Medical Center.

🔬 Contributions and Research Focus

Dr. Uwaifo’s research expertise encompasses Endocrinology, Diabetes, Human Metabolism, Internal Medicine, and Primary Care. His work has notably focused on diabetes, hypertension, obesity, dysmetabolic syndrome, and clinical nutrition. He has been involved in significant clinical and research endeavors, including his role as a Senior Clinical Research Scientist at the Ochsner Diabetes and Weight Management Clinical Research Unit and Special Research Volunteer at the National Institutes of Child Health and Development (NICHD).

🏅 Accolades and Recognition

Dr. Uwaifo holds board certifications in Internal Medicine and Endocrinology, Diabetes, and Human Metabolism. He is also an American Society of Hypertension Certified Clinical Specialist in Hypertension Care and is certified by the American Board of Obesity Medicine. His contributions to the field are reflected in his numerous teaching activities, including direct teaching and supervision of medical students, residents, and clinical fellows, as well as his involvement in CME lectures and symposia.

🌍 Impact and Influence

Dr. Uwaifo’s influence extends through his roles as a mentor and educator, impacting the training of future endocrinologists and medical professionals. His involvement in curriculum development, clinical teaching, and research mentoring has significantly shaped the field of endocrinology and diabetes care. His leadership in managing complex endocrine disorders and his contributions to clinical research have advanced the understanding and treatment of these conditions.

🌟 Legacy and Future Contributions

Dr. Uwaifo’s legacy is marked by his dedication to advancing medical knowledge and improving patient care in Endocrinology and Diabetes. His ongoing contributions to clinical research and education continue to impact the field positively. His future endeavors are likely to build upon his extensive experience, furthering innovation in endocrinology and continuing to shape the next generation of medical professionals.

📖Publications : 

Prof. Jiarui Chen | Medicine and Dentistry | Best Researcher Award

Published on by Academic Excellence

Prof. Jiarui Chen | Medicine and Dentistry | Best Researcher Award 🏆

professor. Jiarui Chen,The First Affiliated Hospital of Guangxi Medical University, China🎓

Professional Profile 

🎓Early Academic Pursuits👨‍⚕️

Dr. Jiarui Chen embarked on his academic journey at Guangxi Medical University, where he pursued a residency in medicine and earned his Ph.D. His early research focused on innovative approaches in bioinformatics and spinal surgery, laying a strong foundation for his career.

🏥Professional Endeavors 

Currently a resident physician and Ph.D. candidate, Dr. Chen is a prominent member of the Youth Committee of the Guangxi Bioinformatics Society. His role involves contributing to cutting-edge research and fostering advancements in the field. Dr. Chen has authored or co-authored over 7 SCI papers with a cumulative impact factor exceeding 20. He is also a reviewer for esteemed journals such as “Aging,” “Heliyon,” and “Arthritis Research & Therapy.”

🔬Contributions and Research Focus

Dr. Chen’s research primarily centers on spine surgery, pediatric orthopedics, immune diseases, and bone tuberculosis. Notable projects include the “CT Anatomical Analysis of C4 Pedicle and Lateral Mass in Children Aged 0–14 in Southern China,” and his work has significantly impacted understanding and treatment methodologies in these areas. His research has led to valuable insights and advancements in clinical practice.

🏆Accolades and Recognition 

Dr. Chen’s scholarly contributions have earned him recognition within the academic community. His extensive publication record and impact factor highlight his influence in the field of spinal and osteopathy surgery. His role as a reviewer for high-impact journals underscores his commitment to maintaining research quality and integrity.

🌟Impact and Influence 

Dr. Chen’s research has improved patient outcomes and contributed to advancements in medical knowledge. His innovative approaches and findings have impacted both clinical practices and scientific understanding, particularly in spinal surgery and immune diseases.

🌱Legacy and Future Contributions

Looking ahead, Dr. Chen aims to continue his research in spinal surgery and immune diseases, with a focus on developing novel treatment strategies and enhancing patient care. His work is poised to make lasting contributions to the field, shaping future research and clinical practices.

📖Publications : 

Paper Title: Prediction model for spinal cord injury in spinal tuberculosis patients using multiple machine learning algorithms: a multicentric study
Authors: Feng, S., Wang, S., Liu, C., Wei, W., Zhan, X.
Journal: Scientific Reports
Volume: 14
Issue: 1
Pages: 7691
Year: 2024

Paper Title: Age and flexors as risk factors for cervical radiculopathy: A new machine learning method
Authors: Pan, S., Liu, C., Chen, J., Ye, Y., Zhan, X.
Journal: Medicine (United States)
Volume: 103
Issue: 4
Pages: E36939
Year: 2024

Paper Title: Identification of osteosarcoma m6A-related prognostic biomarkers using artificial intelligence: RBM15
Authors: Jiang, J., Qu, H., Zhan, X., Yao, Y., Liu, C.
Journal: Scientific Reports
Volume: 13
Issue: 1
Pages: 5255
Year: 2023

Paper Title: Application of machine learning in prediction of bone cement leakage during single-level thoracolumbar percutaneous vertebroplasty
Authors: Deng, G., Zhu, J., Lu, Q., Wang, Y., Zhan, X.
Journal: BMC Surgery
Volume: 23
Issue: 1
Pages: 63
Year: 2023

Paper Title: Identification of clinical heterogeneity and construction of a novel subtype predictive model in patients with ankylosing spondylitis: An unsupervised machine learning study
Authors: Sun, X., Zhou, C., Zhu, J., Zhan, X., Liu, C.
Journal: International Immunopharmacology
Volume: 117
Pages: 109879
Year: 2023

Paper Title: MEG3 alleviates ankylosing spondylitis by suppressing osteogenic differentiation of mesenchymal stem cells through regulating microRNA-125a-5p-mediated TNFAIP3
Authors: Liu, C., Liang, T., Zhang, Z., Zhan, X., Ren, L.
Journal: Apoptosis
Volume: 28
Issue: 3-4
Pages: 498–513
Year: 2023

Paper Title: MMP9 and STAT1 are biomarkers of the change in immune infiltration after anti-tuberculosis therapy, and the immune status can identify patients with spinal tuberculosis
Authors: Zhou, C., Liang, T., Jiang, J., Liu, C., Zhan, X.
Journal: International Immunopharmacology
Volume: 116
Pages: 109588
Year: 2023

Paper Title: Comprehensive AI-assisted tool for ankylosing spondylitis based on multicenter research outperforms human experts
Authors: Li, H., Tao, X., Liang, T., Zhan, X., Liu, C.
Journal: Frontiers in Public Health
Volume: 11
Pages: 1063633
Year: 2023

Paper Title: Difference between the blood samples of patients with bone and joint tuberculosis and patients with tuberculosis studied using machine learning
Authors: Ye, Z., Zhu, J., Liu, C., Wang, Y., Zhan, X.
Journal: Frontiers in Surgery
Volume: 9
Pages: 1031105
Year: 2023

Paper Title: Epidemiological characteristics of ankylosing spondylitis in Guangxi Province of China from 2014 to 2021
Authors: Sun, X., Zhou, C., Chen, L., Zhan, X., Liu, C.
Journal: Archives of Medical Science
Volume: 19
Issue: 4
Pages: 1049–1058
Year: 2023

Prof. Chong Liu | Medicine and Dentistry | Best Researcher Award

Published on by Academic Excellence

Prof. Chong Liu | Medicine and Dentistry | Best Researcher Award 🏆

professor. Chong Liu,The First Affiliated Hospital of Guangxi Medical University, China🎓

Professional Profile 

📚 Early Academic Pursuits

Chong Liu is a distinguished professor at The First Affiliated Hospital of Guangxi Medical University, specializing in Spinal and Osteopathy Surgery. He completed his Ph.D. and postdoctoral qualifications, which laid a strong foundation for his career in medicine. He began his academic journey with a focus on spinal and orthopedic research, which led him to become an Associate Chief Physician and Associate Professor. His early academic work emphasized advancing understanding and treatment methodologies in his field.

🏥 Professional Endeavors

Clinical and Research Roles

Dr. Liu has made significant contributions as a Master’s supervisor and committee member of various professional associations, including the Chinese Association of Integrative Medicine. He has led a National Natural Science Foundation project and four provincial projects, reflecting his leadership in the field. His extensive experience includes overseeing multiple research projects, such as the CT Anatomical Analysis of C4 Pedicle and Lateral Mass in Children Aged 0–14 in Southern China, and others related to osteogenic differentiation and ankylosing spondylitis.

Editorial and Review Roles

Dr. Liu serves as a reviewer for prestigious journals such as the Journal of Innate Immunity and the Journal of Investigative Surgery. His role in these journals involves evaluating manuscripts, providing feedback, and ensuring the quality of published research.

🌟 Contributions and Research Focus

Chong Liu’s research has advanced the fields of spinal surgery, pediatric orthopedics, immune diseases, and bone tuberculosis. His work has led to the development of new treatment methodologies and provided valuable insights into complex medical conditions. His research has notably improved patient outcomes and contributed to the scientific community’s understanding of spinal and osteopathy issues.

🏅 Accolades and Recognition

Dr. Liu has been recognized for his contributions to the field with various roles and responsibilities, including leading significant research projects and holding committee positions in professional associations. His work has been widely published and cited, reflecting his impact on both clinical practice and scientific research.

🌍 Impact and Influence

Dr. Liu’s extensive research and clinical work have had a profound impact on spinal surgery and orthopedics, particularly in pediatric and immune-related conditions. His contributions have not only advanced medical knowledge but also improved patient care and outcomes in these areas.

🚀 Legacy and Future Contributions

Chong Liu continues to be a leading figure in his field, with ongoing research and projects aimed at furthering the understanding and treatment of spinal and osteopathic conditions. His legacy includes a commitment to advancing medical science and improving patient care, with a focus on integrating innovative research findings into clinical practice.

📖Publications : 

Paper Title: Exploration of the combined role of immune checkpoints and immune cells in the diagnosis and treatment of ankylosing spondylitis: a preliminary study immune checkpoints in ankylosing spondylitis

Authors: Huang, F., Su, Z., Huang, Y., Liu, C., Yu, C.
Journal: Arthritis Research and Therapy
Volume: 26
Issue: 1
Pages: 115
Year: 2024

Paper Title: Prediction model for spinal cord injury in spinal tuberculosis patients using multiple machine learning algorithms: a multicentric study

Authors: Feng, S., Wang, S., Liu, C., Wei, W., Zhan, X.
Journal: Scientific Reports
Volume: 14
Issue: 1
Pages: 7691
Year: 2024

Paper Title: Development and validation of a diagnostic model to differentiate spinal tuberculosis from pyogenic spondylitis by combining multiple machine learning algorithms

Authors: Huang, C., Zhuo, J., Liu, C., Chen, L., Zhan, X.
Journal: Biomolecules and Biomedicine
Volume: 24
Issue: 2
Pages: 401–410
Year: 2024

Paper Title: Age and flexors as risk factors for cervical radiculopathy A new machine learning method

Authors: Pan, S., Liu, C., Chen, J., Ye, Y., Zhan, X.
Journal: Medicine (United States)
Volume: 103
Issue: 4
Pages: E36939
Year: 2024

Paper Title: Prediction of additional hospital days in patients undergoing cervical spine surgery with machine learning methods

Authors: Zhang, B., Huang, S., Zhou, C., Liu, C., Zhan, X.
Journal: Computer Assisted Surgery
Volume: 29
Issue: 1
Pages: 2345066
Year: 2024

Paper Title: Exploring the causal relationship between inflammatory cytokines and inflammatory arthritis: A Mendelian randomization study

Authors: Pan, S., Wu, S., Wei, Y., Zhan, X., Liu, C.
Journal: Cytokine
Volume: 173
Pages: 156446
Year: 2024

Paper Title: Development and validation of a machine learning-based nomogram for predicting HLA-B27 expression

Authors: Zhu, J., Tan, W., Zhan, X., Chen, L., Liu, C.
Journal: BMC Immunology
Volume: 24
Issue: 1
Pages: 32
Year: 2023

Paper Title: Predictors of osteoporotic fracture in postmenopausal women: a meta-analysis

Authors: Long, G., Liu, C., Liang, T., Qin, Z., Zhan, X.
Journal: Journal of Orthopaedic Surgery and Research
Volume: 18
Issue: 1
Pages: 574
Year: 2023

Paper Title: Proteomic analysis to identification of hypoxia related markers in spinal tuberculosis: a study based on weighted gene co-expression network analysis and machine learning

Authors: Wu, S., Liang, T., Jiang, J., Zhan, X., Liu, C.
Journal: BMC Medical Genomics
Volume: 16
Issue: 1
Pages: 142
Year: 2023

Paper Title: To infer the probability of cervical ossification of the posterior longitudinal ligament and explore its impact on cervical surgery

Authors: Zhu, J., Lu, Q., Zhan, X., Wei, W., Liu, C.
Journal: Scientific Reports
Volume: 13
Issue: 1
Pages: 9816
Year: 2023

Dr. Oleg Tsuprykov | Medicine and Dentistry | Best Researcher Award

Published on by Academic Excellence

Dr. Oleg Tsuprykov | Medicine and Dentistry | Best Researcher Award🏆

Doctor. Oleg Tsuprykov, HMU Health and Medical University, Germany🎓

Professional Profile 

🩺📚 Early Academic Pursuits

Oleg Tsuprykov was born in 1982 in Ukraine. He pursued his early education in Ukraine, where he displayed a strong aptitude for the sciences. In 2005, he graduated with distinction from the State Medical Maxim Gorki University in Donetsk, earning a degree in Medicine and the qualification of a physician. His academic journey continued at the National P.-L.-Shupik Medical Academy for Postgraduate Education, where he completed his internship in clinical laboratory diagnostics in 2007.

🏆 Professional Endeavors

Early Career and Research

From August 2007 to March 2009, Tsuprykov was a fellow in the Early Stage Research Training Programme at the Center for Cardiovascular Research, Charité Campus Mitte, Berlin. Here, he worked on cardiovascular disease mechanisms under the guidance of Prof. Hocher and Prof. Kappert. In March 2009, he completed a course on laboratory animals and experiments.

Doctoral Research

In April 2009, he began his doctoral research at the Center for Cardiovascular Research, Charité Campus Mitte. His thesis focused on comparing the renal effects of DPP-4 inhibitor linagliptin with angiotensin receptor blocker telmisartan in a rat model of chronic kidney disease. His research included extensive morphological analyses and protein expression studies.

Professional Experience at DIFE

From October 2012 to April 2016, Tsuprykov continued his doctoral research at the German Institute of Human Nutrition (DIFE) in Potsdam. His work included histochemical staining methods, morphometric analyses, immunohistochemistry, immunofluorescence, Western Blot, real-time quantitative PCR, DNA methylation, and statistical data analysis. His contributions were significant, leading to several publications.

Current Role

Since May 2024, Tsuprykov has been an academic employee specializing in teaching and research at the Institute for Mind, Brain and Behavior at HMU Health and Medical University in Potsdam, Germany. His responsibilities include conducting seminars on neuroanatomy and overseeing research projects on astrocyte morphology and brain biomarkers in obese patients.

🌟 Contributions and Research Focus

Oleg Tsuprykov’s research has significantly contributed to the fields of neuroanatomy, cardiovascular disease, and clinical biomarkers. His work on the validation of novel biomarkers and the development of innovative diagnostic methods has had a profound impact on medical diagnostics and patient care.

🏅 Accolades and Recognition

Tsuprykov defended his doctoral thesis with summa cum laude in June 2017 at the Charité – Universitätsmedizin Berlin. His publications and contributions to various research projects have earned him recognition in the scientific community.

🌍 Impact and Influence

Through his research and professional endeavors, Oleg Tsuprykov has influenced the fields of neuroanatomy, laboratory medicine, and cardiovascular research. His innovative approach to diagnostics and biomarker validation has improved patient outcomes and set new standards in medical research.

🚀 Legacy and Future Contributions

Oleg Tsuprykov continues to make strides in his current role at HMU Health and Medical University. His ongoing research on astrocytes and brain biomarkers promises to further our understanding of neurological conditions and their treatments. His legacy is one of dedication to scientific excellence and a commitment to advancing medical knowledge.

📖Publications : 

Paper Title: Paternal eNOS deficiency in mice affects glucose homeostasis and liver glycogen in male offspring without inheritance of eNOS deficiency itself

Authors: Hocher, B., Lu, Y.-P., Reichetzeder, C., … Krämer, B.K., Hasan, A.A.
Journal: Diabetologia
Volume: 65
Issue: 7
Pages: 1222–1236
Year: 2022

Paper Title: Free vitamin D is independently associated with systolic blood pressure in diabetic patients with impaired kidney function

Authors: Zeng, S., Bachert, D., Pavkovic, M., … Hocher, B., Elitok, S.
Journal: Clinical Nephrology
Volume: 97
Issue: 2
Pages: 63–69
Year: 2022

Paper Title: Opposite correlation of 25-hydroxy-vitamin D- and 1,25-dihydroxy-vitamin D-metabolites with gestational age, bone- and lipid-biomarkers in pregnant women

Authors: Tsuprykov, O., Elitok, S., Buse, C., … Krämer, B.K., Hocher, B.
Journal: Scientific Reports
Volume: 11
Issue: 1
Pages: 1923
Year: 2021

Paper Title: Relationship Between Vitamin D and Hormones Important for Human Fertility in Reproductive-Aged Women

Authors: Chu, C., Tsuprykov, O., Chen, X., … Krämer, B.K., Hocher, B.
Journal: Frontiers in Endocrinology
Volume: 12
Pages: 666687
Year: 2021

Paper Title: Linagliptin and telmisartan induced effects on renal and urinary exosomal miRNA expression in rats with 5/6 nephrectomy

Authors: Delić, D., Wiech, F., Urquhart, R., … Hocher, B., Klein, T.
Journal: Scientific Reports
Volume: 10
Issue: 1
Pages: 3373
Year: 2020

Paper Title: Mechanisms of GLP-1 receptor–independent renoprotective effects of the dipeptidyl peptidase type 4 inhibitor linagliptin in GLP-1 receptor knockout mice with 5/6 nephrectomy

Authors: Hasan, A.A., von Websky, K., Reichetzeder, C., … Kleuser, B., Hocher, B.
Journal: Kidney International
Volume: 95
Issue: 6
Pages: 1373–1388
Year: 2019

Paper Title: Comparison of free and total 25-hydroxyvitamin D in normal human pregnancy

Authors: Tsuprykov, O., Buse, C., Skoblo, R., Hocher, B.
Journal: Journal of Steroid Biochemistry and Molecular Biology
Volume: 190
Pages: 29–36
Year: 2019

Paper Title: Folate treatment of pregnant rat dams abolishes metabolic effects in female offspring induced by a paternal pre-conception unhealthy diet

Authors: Li, J., Lu, Y.-P., Tsuprykov, O., … Lin, G., Hocher, B.
Journal: Diabetologia
Volume: 61
Issue: 8
Pages: 1862–1876
Year: 2018

Paper Title: Reference intervals for measured and calculated free 25-hydroxyvitamin D in normal pregnancy

Authors: Tsuprykov, O., Buse, C., Skoblo, R., Haq, A., Hocher, B.
Journal: Journal of Steroid Biochemistry and Molecular Biology
Volume: 181
Pages: 80–87
Year: 2018

Paper Title: Why should we measure free 25(OH) vitamin D?

Authors: Tsuprykov, O., Chen, X., Hocher, C.-F., … Lianghong Yin, Hocher, B.
Journal: Journal of Steroid Biochemistry and Molecular Biology
Volume: 180
Pages: 87–104
Year: 2018

Prof. Kenneth Nugent | Medicine and Dentistry | Academic Excellence Award

Published on by Academic Excellence

Prof. Kenneth Nugent | Medicine and Dentistry | Academic Excellence Award 🏆

 Professor . Kenneth Nugent . Texas tech University health Sciences Center, United States🎓

Professional Profile 

🩺Early Academic Pursuits 📚

Kenneth M. Nugent, MD, is a distinguished physician and academic in the field of Internal Medicine. His early academic journey set a strong foundation for his future contributions in medicine. Dr. Nugent’s dedication to the study of pulmonary and critical care medicine began during his formative years, leading to a deep and lasting commitment to these specialized fields.

🏥Professional Endeavors 

Dr. Nugent currently serves as a Full Professor in the Department of Internal Medicine at Texas Tech University Health Sciences Center (TTUHSC) in Lubbock. He has been instrumental in shaping the Pulmonary Medicine and Critical Care Fellowship program, where he holds the position of Director. His role encompasses a blend of teaching, clinical service, and academic leadership.

Before joining TTUHSC, Dr. Nugent accumulated extensive experience as a researcher, where his work focused on advancing the field of pulmonary medicine. His clinical and academic expertise has greatly contributed to the development of new protocols and practices in the management of pulmonary and critical care patients.

🔬Contributions and Research Focus

Dr. Nugent’s research interests are centered around pulmonary and critical care medicine, with a focus on improving patient outcomes through innovative clinical practices and evidence-based research. His contributions have been pivotal in advancing the understanding and treatment of complex pulmonary conditions. His research has been recognized for its impact on clinical practices and patient care strategies.

🏅Accolades and Recognition 

Dr. Nugent’s excellence in his field has been acknowledged through numerous honors and awards. In January 2023, he was elected to the Alpha Omega Alpha Honor Society, a prestigious national medical honor society recognizing commitment to professionalism, leadership, scholarship, research, and community service. Additionally, he was listed in the Top 2% by a Stanford University Study for References with the Most Citations for 2020, highlighting his significant influence and contribution to medical research.

🌟Impact and Influence

Dr. Nugent’s impact extends beyond his immediate academic and clinical roles. His mentorship and leadership have shaped the careers of numerous medical professionals. His innovative approaches and dedication to patient care have influenced practices within his department and the broader medical community.

🌐Legacy and Future Contributions 

As Dr. Nugent continues his career, his focus remains on advancing the field of pulmonary and critical care medicine through research, teaching, and clinical practice. His legacy is marked by his commitment to improving patient care, mentoring future medical leaders, and contributing to the ongoing development of medical knowledge and practice.

📖Publications :